Acapella vs Flutter Devices for Improving Breathing and Lung Function After Lobectomy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age35-54
SponsorRiphah International University

About this trial

Lobectomy patients frequently experience postoperative respiratory complications such as secretion retention, dyspnea, impaired gas exchange, and reduced lung function, which can delay recovery. Oscillatory Positive Expiratory Pressure (OPEP) devices such as Acapella and Flutter are commonly used to improve airway clearance and pulmonary function. This study aims to compare the effects of Acapella and Flutter devices on secretion clearance, dyspnea, arterial blood gases, and lung function in post-lobectomy patients.

Eligibility criteria

Qualifiers

Patients aged 35 to 54 years

Both male and female patients

Patients who have undergone lobectomy surgery

Hemodynamically stable patients

Disqualifiers

Hemodynamically unstable patients

Patients within less than 48 hours post-surgery

Presence of pneumothorax or air leak complications

Patients with recent major trauma or additional surgery

Trial design

Treatments tested in this trial

  • Acapella Device Therapy (Experimental Arm 1):
  • Flutter Device Therapy (Experimental Arm 2):

Treatment groups

28 Participants
are divided into 2 treatment groups